The triplet therapy was effective only in patients with nonmutated PIK3CA and ESR1 genes, achieving a median PFS of 9.1 ...
Money Talks News on MSN
$32K Alzheimer drugs offer modest brain benefits
Controversial anti-amyloid therapies costing up to $32,000 annually offer modest hope for Alzheimer's patients while carrying ...
Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.
The investigational, potentially first-in-class agent tinostamustine (EDO-S101) has earned FDA orphan drug designation (ODD) ...
The Indian Council of Medical Research’s latest synthesis (covering up to 2023) estimates over 100 million Indian adults ...
Medpage Today on MSN
Semaglutide's MASH Benefits Extend Beyond Weight Loss
WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...
Nektar Therapeutics has pivoted from oncology to focus on autoimmune and inflammatory diseases. Read why I rate NKTR stock a ...
The D-CARD Africa Project is designed to integrate non-communicable disease screening into existing health services, ...
MedPage Today on MSN
WIC Telehealth Program Improved Diet, Had Modest Impact on Weight Gain in Pregnancy
Recommendations for optimal gestational weight gain are different depending on a woman's body mass index (BMI), ranging from ...
Meet Antony Vaidyan, a Catholic vaidyan (traditional doctor) in Kerala, India, who merges traditional Ayurvedic medicine with deep Christian faith, seeing no conflict between turmeric and psalms.
A cholesterol-lowering regimen that combines PCSK9 inhibitor alirocumab with statin therapy safely reduced low-density ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results